跳至主要内容
临床试验/NCT03124966
NCT03124966已完成不适用

Accuracy of Hemoglobin Measurement for Various Rainbow Pulse Oximeter Sensors

Masimo Corporation4 个研究点 分布在 1 个国家目标入组 118 人开始时间: 2009年12月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
118
试验地点
4
主要终点
Accuracy of Sensor by Arms Calculation

研究概览

简要总结

In this study, the concentration of hemoglobin within the subject's blood will be reduced in a controlled manner by administering fluids intravenously. The accuracy of a noninvasive hemoglobin sensor(s) will be assessed by comparison to hemoglobin measurements from a laboratory analyzer.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Has physical status between ASA 1 or 2
  • Able to communicate in English

排除标准

  • Pregnant or sexually active without birth control.
  • Hemoglobin less than 11g/dL
  • Known alcohol or drug abuse
  • Skin abnormalities affecting the digits such as psoriasis, eczema, angioma, scar tissue, burn, fungal infection
  • Nail polish
  • Head injury with loss of consciousness within the last year
  • Known neurological and psychiatric conditions.
  • Known concurrent chronic usage of psychoactive or anti-convulsive drugs within the last 90 days, or use in the last 7 days (i.e. tricyclic antidepressants, MAO inhibitors, lithium, neuroleptics, anxiolytics or antipsychotics. Except SSRIs
  • Subject has any medical condition which, in the judgement of the investigator, renders them inappropriate for participation in this study, such as Raynaud's syndrome
  • Hypertension: Systolic BP >= 140 mmHg or Diastolic BP >= 90 mmHg
  • Baseline heart rate <50 beats per minute
  • Study Site 2:
  • Inclusion Criteria:
  • Male or female
  • 18-35 years of age
  • Physical status of ASA I or II
  • Able to read and communicate in English
  • Has signed written informed consent
  • If female, non pregnant. If female subject is currently sexually active and not on birth control they must have a negative pregnancy test prior to study enrollment.
  • Exclusion Criteria
  • Age less than 18 yrs and greater than 35 years
  • Hemoglobin less than 12 g/dL
  • ASA physical status of III, IV, or V
  • Pregnant or sexually active without birth control
  • Subject has known drug or alcohol abuse
  • Subject has skin abnormalities affecting the digits such as psoriasis, eczema, angioma, scar tissue, burn, fungal infection, substantial skin breakdown, nail polish or acrylic nails.
  • Subject has experienced a head injury with loss of consciousness within the last year
  • Subject has known neurological and psychiatric disorder that interferes with the subjects level of consciousness
  • Known or concurrent chronic usage of psychoactive or anticonvulsive drugs within the last 90 days, or any use in the last 7 day (i.e. tricyclic antidepressants, MAO inhibitors, lithium, neuroleptics, anxiolytics or antipsychotics, except SSRIs).
  • Subject has any medical condition which in the judgment of the investigator, renders them inappropriate for participation in this study, such as Raynauds Syndrome.
  • Hypertension: Systolic BP >140 mmHg or Diastolic BP > 90 mmHg.
  • Baseline heart rate < 50 bpm.
  • Inability to tolerate sitting still or minimal movement for up to 90 minutes

研究组 & 干预措施

Noninvasive Hemoglobin Sensor

Experimental

All subjects are enrolled into the test group and all will receive the pulse oximeter sensor.

干预措施: Pulse Oximeter sensor (Device)

结局指标

主要结局

Accuracy of Sensor by Arms Calculation

时间窗: 1-3 hours

Accuracy will be determined by comparing the noninvasive hemoglobin measurement of the pulse oximeter to the hemoglobin value obtained from a blood sample and calculating the arithmetic root mean square(Arms) error value.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验